Skip to main content
. 2021 Oct 11;78(12):4023–4036. doi: 10.1007/s00284-021-02662-y

Table 2.

A summary of the therapeutic properties of bacteriophage against infections caused by colistin-resistant Gram-negative bacteria

Author name Year Phage Organism Result Ref.
Ebrahimi et al 2020 IsfAB78 Colistin-resistant MDR A. baumannii IsfAB78 phage was able to significantly lyse culture and biofilm of MDR A. baumannii [86]
Hao et al 2019 ɸNJS1 Colistin-resistant CRKP Colistin-resistant CRKP was also shown to be more susceptible to ɸNJS1 phage compared to wild-type bacteria when grown in biofilms or moth larvae and during mammalian colon colonization [87]
Shokri et al 2017 Psu1, Psu2, and Psu3 MDR, XDR and PDR isolates of colistin-resistant P. aeruginosa Phage cocktails showed antibacterial activity and completely destroyed the bacterial cells [88]
Abdelkader et al 2020 PMK34 PDR colistin-resistant A. baumannii PDR colistin-resistant A. baumannii strains were susceptible to the PMK34 phage [89]
Manohar et al 2019 myPSH2311, myPSH1235, and myPSH1140 Meropenem and colistin-resistant E. coli, K. pneumoniae, and Enterobacter spp. There was a reduction in bacterial load and efficacy was observed against all bacteria [90]
Blasco et al 2019 ElyA1 and ElyA2 endolysins [from phage Ab1051Φ and Ab1052Φ] Colistin-resistant MDR P. aeruginosa, MDR A. baumannii, and carbapenemase-producing K. pneumoniae isolates ElyA1 illustrated antibacterial activity and combination of colistin and ElyA1 decreased the MIC of colistin in all isolates [93]
Bernasconi et al 2017 PYO, INTESTI, and Septaphage MDR carbapenemase-producers, colistin-resistant E. coli and Proteus spp. isolates Although Septaphage had no antibacterial activity, carbapenemase producers and colistin-resistant isolates were susceptible to PYO and INTESTI [94]
Aslam et al 2019 AB‐PA01, AB‐PA01 m1, Navy phage cocktail1, and Navy phage cocktail2 for patient one, AB‐PA01 for patient two, and single lytic phage for patient three Colistin-resistant MDR P. aeruginosa and B. dolosa Phage therapy was well related to clinical recovery in lung transplant recipients with MDR Gram-negative bacterial infections [95]
Vukotic et al 2020 vB_AbaM_ISTD and vB_AbaM_NOVI Colistin-resistant A. baumannii Two colistin-resistant isolates were also sensitive to both NOVI and ISTD phages [96]
Schirmeier et al 2018 Artilysin Art-175 Colistin-resistant mcr-1-positive E. coli isolates Art-175 showed a high antimicrobial activity against all mcr-1 colistin-resistant E. coli isolates and the number of bacteria was reduced [97]
Defraine et al 2016 Artilysin Art-175 MDR colistin susceptible and resistant A. baumannii Art-175 had high bactericidal properties against all isolates, even colistin-resistant isolates [98]